Labcorp Reaffirms 2026–2029 Long-Term Outlook Following CMS Preliminary Medicare Payment Rate Release; Expects Compound Annual Adj EPS Growth Of 8.5%-11.5% In 2026-2029

Labcorp Holdings Inc. reaffirmed its long-term outlook for 2026-2029 following the release of preliminary Medicare payment rates by CMS. The company anticipates compound annual revenue growth of 5% to 8%, adjusted EPS growth of 8.5% to 11.5%, and adjusted operating margin expansion of 75 to 150 basis points by the end of 2029. Labcorp is also evaluating the impact of these payment rates on its financial guidance for 2027, which will be provided in February 2027.